Liver International
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
Table of contents
- 263
-
Issue Information| 2022
- 268
-
The complexity of cholangiocarcinoma goes beyond clinical practice: Challenges in trials design and interpretationDa Fonseca, Leonardo G. / Forner, Alejandro et al. | 2022
- 271
-
Meaning of non‐overlapping patients between the MAFLD and NAFLD definitionsChan, Wah‐Kheong / Wong, Vincent W.‐S. et al. | 2022
- 274
-
Is immunosuppression truly associated with worse outcomes in autoimmune hepatitis patients with COVID‐19?Terziroli Beretta‐Piccoli, Benedetta / Lleo, Ana et al. | 2022
- 277
-
Systematically comparing epidemiological and clinical features of MAFLD and NAFLD by meta‐analysis: Focusing on the non‐overlap groupsAyada, Ibrahim / van Kleef, Laurens A. / Alferink, Louise J. M. et al. | 2022
- 288
-
State of the art treatment of hepatitis B virus hepatocellular carcinoma and the role of hepatitis B surface antigen post‐liver transplantation and resectionSchemmer, Peter / Burra, Patrizia / Hu, Rey‐Heng et al. | 2022
- 299
-
Moderation effect of economic status in the association between early life famine exposure and MAFLD in adulthoodWang, Yuying / Zhang, Wen / Xia, Fangzhen et al. | 2022
- 309
-
Differences in the hepatitis C virus cascade of care and time to initiation of therapy among vulnerable subpopulations using a mobile unit as point‐of‐careValencia, Jorge / Lazarus, Jeffrey V. / Ceballos, Francisco C. et al. | 2022
- 320
-
Comparison of biochemical response during antiviral treatment in patients with chronic hepatitis B infectionKim, Si Ho / Cho, Eun Ju / Jang, Boo‐ok et al. | 2022
- 330
-
HCV disease burden and population segments in SwitzerlandBihl, Florian / Bruggmann, Philip / Castro Batänjer, Erika et al. | 2022
- 340
-
Trends in the Prevalence of Hepatitis C Virus Infection based on the Insurance Status in the United States from 2013 to 2018Kim, Donghee / Cholankeril, George / Dennis, Brittany B. et al. | 2022
- 350
-
Long‐term prognosis of patients with alcohol‐related liver disease or non‐alcoholic fatty liver disease according to metabolic syndrome or alcohol useDecraecker, Marie / Dutartre, Dan / Hiriart, Jean‐Baptiste et al. | 2022
- 363
-
Changes in bile acid subtypes and long‐term successful weight‐loss in response to weight‐loss diets: The POUNDS lost trialHeianza, Yoriko / Zhou, Tao / He, Hua et al. | 2022
- 374
-
Accuracy of controlled attenuation parameter for assessing liver steatosis in individuals with morbid obesity before bariatric surgeryTavaglione, Federica / De Vincentis, Antonio / Bruni, Vincenzo et al. | 2022
- 384
-
Rates of decompensation, hepatocellular carcinoma and mortality in AMA‐negative primary biliary cholangitis cirrhosisJohn, Binu V. / Dahman, Bassam / Deng, Yangyang et al. | 2022
- 394
-
Sarcopenia is highly prevalent in children with autoimmune liver diseases and is linked to visceral fat and parent‐perceived general healthAmevor, Antoinette A. / Yodoshi, Toshifumi / Trout, Andrew T. et al. | 2022
- 402
-
MYO5B‐associated diseases: Novel liver‐related variants and genotype‐phenotype correlationWang, Li / Qiu, Yi‐Ling / Xu, Hong‐Mei et al. | 2022
- 412
-
Causal effects from non‐alcoholic fatty liver disease on kidney function: A Mendelian randomization studyPark, Sehoon / Lee, Soojin / Kim, Yaerim et al. | 2022
- 419
-
Portosystemic shunt is an effective treatment for complications of portal hypertension in hepatic myeloid metaplasia and improves nutritional statusAspite, Silvia / Schepis, Filippo / Roccarina, Davide et al. | 2022
- 425
-
Association of skeletal muscle index with postoperative acute kidney injury in living donor hepatectomy: A retrospective single‐centre cohort studySim, Ji‐Hoon / Kwon, Hye‐Mee / Jun, In‐Gu et al. | 2022
- 435
-
Fibrin clot quality in acutely ill cirrhosis patients: Relation with outcome and improvement with coagulation factor concentratesBlasi, Annabel / Patel, Vishal C. / Spanke, Eva N. H. E. et al. | 2022
- 444
-
Glycosylated 4‐methylumbelliferone as a targeted therapy for hepatocellular carcinomaWeiz, Gisela / Molejon, Maria I. / Malvicini, Mariana et al. | 2022
- 458
-
Pattern of progression of intrahepatic cholangiocarcinoma: Implications for second‐line clinical trialsTovoli, Francesco / Garajová, Ingrid / Gelsomino, Fabio et al. | 2022
- 468
-
Aurora kinase A regulates liver regeneration through macrophages polarization and Wnt/β‐catenin signallingYin, Yanze / Kong, Defu / He, Kang et al. | 2022
- 479
-
NAFLD vs ALD: What if there was only one entity?Decraecker, Marie et al. | 2022
- 480
-
Is it time to get rid of the biopsy mandate in adults with suspected autoimmune hepatitis? Lessons from the COVID‐19 pandemicShorbagi, Ali I. et al. | 2022
- i
-
Issue CoverWang, Yuying / Zhang, Wen / Xia, Fangzhen et al. | 2022